The first evidence that CD271 consequentially determines melanoma cell behavior was provided by Shonukan et al. who demonstrated the specific interaction of CD271 with the actin cytoskeleton via the actin-bundling protein fascin (FSCN1). The gene discussed is FSCN1; the disease is melanoma.